S.Biomedics Co., Ltd. (KOSDAQ:304360)
South Korea
· Delayed Price · Currency is KRW
36,200
+400 (1.12%)
At close: Mar 6, 2026
S.Biomedics Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 5, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 420,475 | 203,202 | 130,376 | - | - | - | |
| Market Cap Growth | 65.73% | 55.86% | - | - | - | - | |
| Enterprise Value | 423,745 | 206,789 | 133,226 | - | - | - | |
| Last Close Price | 33950.00 | 17300.00 | 11500.00 | - | - | - | |
| PS Ratio | 24.79 | 14.80 | 9.95 | - | - | - | |
| PB Ratio | 31.43 | 11.10 | 10.55 | - | - | - | |
| P/TBV Ratio | 75.70 | 17.74 | 18.92 | - | - | - | |
| EV/Sales Ratio | 24.98 | 15.06 | 10.16 | - | - | - | |
| Debt / Equity Ratio | 1.06 | 1.03 | 0.97 | 13.33 | 1.78 | 1.17 | |
| Net Debt / Equity Ratio | -0.32 | -0.28 | 0.11 | 6.16 | -1.58 | -1.43 | |
| Net Debt / EBITDA Ratio | 0.89 | 1.39 | -0.30 | -2.85 | 1.91 | 0.97 | |
| Net Debt / FCF Ratio | 0.56 | 1.06 | -0.17 | -0.51 | 1.61 | 1.22 | |
| Asset Turnover | 0.45 | 0.36 | 0.47 | 0.57 | 0.50 | 0.26 | |
| Inventory Turnover | 3.43 | 2.99 | 3.33 | 5.14 | 6.18 | 6.07 | |
| Quick Ratio | 4.04 | 2.20 | 1.67 | 0.75 | 3.19 | 1.96 | |
| Current Ratio | 4.71 | 2.49 | 2.05 | 0.95 | 3.44 | 2.12 | |
| Return on Equity (ROE) | -55.51% | -37.96% | -138.29% | -195.41% | -121.47% | -97.95% | |
| Return on Assets (ROA) | -11.24% | -8.89% | -13.30% | -11.13% | -16.13% | -26.13% | |
| Return on Capital Employed (ROCE) | -19.10% | -16.60% | -24.70% | -30.00% | -34.00% | -74.60% | |
| Earnings Yield | -2.28% | -3.29% | -7.92% | - | - | - | |
| FCF Yield | -1.83% | -2.41% | -6.13% | - | - | - | |
| Buyback Yield / Dilution | -3.69% | -5.22% | -6.97% | -0.67% | -0.42% | -3.93% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.